Paclitaxel, uracil plus tegafur (UFT) and leucovorin (LV) in patients with pre-treated metastatic breast cancer: Preclinical rationale and phase I study results

被引：0
|
作者：
Passardi, A. [1 ]
Massa, I. [1 ]
Milandri, C. [1 ]
Cecconetto, L. [1 ]
Calpona, S. [1 ]
Ibrahim, T. [1 ]
Ridolfi, L. [1 ]
Zoli, W. [1 ]
Frassineti, L. [1 ]
Maltoni, R. [1 ]
机构：
[1] Ist Oncol Romagnolo, Forll, Italy
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：XI11 / XI12
页数：2
相关论文
共 50 条
  • [41] Irinotecan combined with docetaxel in pre-treated metastatic breast cancer patients: a phase II study
    Stathopoulos, GP
    Tsavdaridis, D
    Malamos, NA
    Rigatos, SK
    Kosmas, C
    Pergantas, N
    Stathopoulos, JG
    Xynotroulas, J
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 56 (05) : 487 - 491
  • [42] A randomized Phase II study of tegafur/uracil (UFT), oral Leucovorin and irinotecan, combination therapy (TEGAFIRI) plus bevacizumab versus FOLFIRI plus bevacizumab for the first-line treatment of patients with metastatic colorectal cancer
    Hasegawa, H.
    Endo, T.
    Ochiai, D.
    Uchida, H.
    Okabayashi, T.
    Imai, S.
    Ishii, Y.
    Tsuruta, M.
    Kitagawa, Y.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S557 - S557
  • [43] Irinotecan combined with docetaxel in pre-treated metastatic breast cancer patients: a phase II study
    G. P. Stathopoulos
    D. Tsavdaridis
    N. A. Malamos
    S. K. Rigatos
    Ch. Kosmas
    N. Pergantas
    J. G. Stathopoulos
    J. Xynotroulas
    Cancer Chemotherapy and Pharmacology, 2005, 56 : 487 - 491
  • [44] Retrospectively Comparative Evaluation of the First- and Second-Line Chemotherapy With Campto and Oxaliplatin Combined With Oral Tegafur/Uracil (UFT)/Leucovorin (LV) in Patients With Metastatic Colorectal Cancer
    Hsiao, Shih-Chuan
    Lin, Jui-Fen
    Chuang, Mao-Te
    Lee, Yu-An
    Wu, Dong-Long
    INTERNATIONAL SURGERY, 2009, 94 (04) : 298 - 303
  • [45] Multicenter phase II study of pre-administrated uracil/tegafur (UFT) plus gemcitabine for unresectable/recurrent pancreatic cancer.
    Nakamori, S
    Endo, W
    Hasuike, Y
    Masutani, S
    Morimoto, T
    Ozato, H
    Shibata, T
    Takeda, Y
    Tohno, K
    Monden, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 345S - 345S
  • [46] A phase I study of uracil/tegafur (LIFT) and oral leucovorin (LV) plus weekly oxaliplatin (OXA) and preoperative radiotherapy (RT) in locally advanced rectal cancer (LARC).
    Aschel, C
    Vitali, ML
    Binda, GA
    Decian, F
    Battistini, G
    Caroti, C
    D'Amico, M
    Ricci, P
    Siragusa, A
    Gallo, L
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 279S - 279S
  • [47] Alternating irinotecan with oxaliplatin combined with UFT plus leucovorin (LV) (SCOUT) in patients with advanced colorectal cancer (ACRC): A phase I/II study
    Sheikh, H.
    Valle, J. W.
    Palmer, K.
    Wilson, G.
    Sjursen, A.
    Craven, O.
    Swindell, R.
    Saunders, M. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [48] Bevacizumab (Bmab) in combination with uracil-tegafur (UFT) and oral leucovorin (LV) in elderly patients (≥75 years old) with metastatic colorectal cancer (mCRC): A multicenter phase II trial (J- BLUE study).
    Shimada, Mitsuo
    Nishina, Tomohiro
    Higashijima, Jun
    Moriwaki, Toshikazu
    Masuishi, Toshiki
    Sakai, Yoshinori
    Ozeki, Mitsuharu
    Negoro, Yuji
    Indou, Shunju
    Denda, Tadamichi
    Sato, Mikio
    Morimoto, Masamitsu
    Nakajima, Go
    Mizuta, Minoru
    Takahashi, Ikuo
    Hiroshima, Yoshinori
    Ishida, Hiroyasu
    Maeba, Takashi
    Hyodo, Ichinosuke
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [49] Phase II and Pharmacological Study of Oral Docetaxel Plus Cyclosporin A in Anthracycline Pre-Treated Metastatic Breast Cancer
    Helgason, Helgi H.
    Koolen, Stijn L. W.
    van Werkhoven, Erik
    Malingre, Mirte M.
    Kruijtzer, C. Marielle F.
    Huitema, Alwin D. R.
    Schot, Margaret E.
    Smit, Wim M.
    Beijnen, Jos H.
    Schellens, Jan H. M.
    CURRENT CLINICAL PHARMACOLOGY, 2014, 9 (02): : 139 - 147
  • [50] Phase II Study of Oral Tegafur/Uracil and Leucovorin plus Bevacizumab as a First-Line Therapy for Elderly Patients with Advanced or Metastatic Colorectal Cancer
    Mizushima, Tsunekazu
    Tamagawa, Hiroshi
    Matsuda, Chu
    Murata, Kohei
    Fukunaga, Mutsumi
    Ota, Hirofumi
    Hasegawa, Junichi
    Tsujie, Masaki
    Fukuzaki, Takayuki
    Hata, Taishi
    Takemasa, Ichiro
    Ikeda, Masataka
    Yamamoto, Hirofumi
    Sekimoto, Mitsugu
    Nezu, Riichiro
    Doki, Yuichiro
    Mori, Masaki
    ONCOLOGY, 2015, 89 (03) : 152 - 158
12345